Yahoo · Oct 28, 2026
Adamas Trust: Q3 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Adamas Trust, Inc. (ADAM) on Wednesday reported a third-quarter loss of $159.
AD
NYSE · ADAMZ
Adamas Trust, Inc. 7.000% Series G Cumulative Redeemable Preferred Stock
Financial Services · Financial - Mortgages
$16.54
Up+$0.39 (+2.41%)
Updated Nov 5, 2026, 7:32 AM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.77B
- P/E ratio
- 5
- Dividend yield
- 10.59%
- 52-week range
- $15.13 – $19.79
- Volume
- 7.08K
- Avg. volume
- 6.45K
Price performance · ADAMZ
ADAMZ price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
ADAMZ closed at $16.54 after 21 trading sessions, up 2.79% for the selected period.
- Last close
- $16.54
- Period change
- +2.79%
- Period low
- $15.13
- Period high
- $16.90
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $16.10 | $16.54 | $16.10 | $16.539 | 7.08K |
| Nov 3, 2026 | $16.05 | $16.155 | $15.95 | $16.15 | 3.94K |
| Nov 2, 2026 | $17.0778 | $17.0778 | $15.8127 | $16.01 | 15.77K |
| Oct 30, 2026 | $16.7525 | $16.7525 | $16.26 | $16.37 | 6.67K |
| Oct 29, 2026 | $16.68 | $16.68 | $16.39 | $16.5299 | 7.49K |
| Oct 28, 2026 | $17.14 | $17.14 | $16.90 | $16.90 | 4.01K |
| Oct 27, 2026 | $16.84 | $16.91 | $16.73 | $16.73 | 4.68K |
| Oct 26, 2026 | $16.89 | $16.89 | $16.72 | $16.8101 | 1.94K |
| Oct 23, 2026 | $16.39 | $16.92 | $16.39 | $16.90 | 9.14K |
| Oct 22, 2026 | $15.80 | $16.7069 | $15.80 | $16.558 | 36.65K |
| Oct 21, 2026 | $15.945 | $16.0851 | $15.80 | $15.80 | 1.9K |
| Oct 20, 2026 | $15.70 | $16.13 | $15.69 | $15.75 | 18.55K |
| Oct 19, 2026 | $15.21 | $15.75 | $15.21 | $15.56 | 23.29K |
| Oct 16, 2026 | $15.78 | $15.78 | $15.13 | $15.13 | 21.49K |
| Oct 15, 2026 | $15.85 | $16.20 | $15.62 | $15.70 | 18.29K |
| Oct 14, 2026 | $15.96 | $16.10 | $15.62 | $15.62 | 22.09K |
| Oct 13, 2026 | $16.135 | $16.135 | $16.0339 | $16.0339 | 3.43K |
| Oct 12, 2026 | $15.98 | $16.20 | $15.98 | $16.20 | 2.8K |
| Oct 9, 2026 | $15.90 | $16.19 | $15.90 | $16.1471 | 6.39K |
| Oct 8, 2026 | $16.17 | $16.1799 | $15.65 | $15.8601 | 21.28K |
| Oct 7, 2026 | $16.52 | $16.52 | $16.09 | $16.09 | 22.46K |
Latest ADAMZ news
The latest Smart Investors Daily articles mentioning ADAMZ.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ADAMZ research
Overview
Company profile and research snapshot.
Company profile
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 30, 2026 | Keefe, Bruyette & Woods | Market Perform | — |
| Oct 29, 2026 | Jones Trading | Buy | — |
| Sep 17, 2026 | Jones Trading | Buy | — |
| Sep 14, 2026 | Jones Trading | Buy | — |
| Sep 11, 2026 | Jones Trading | Buy | — |
News briefing
Generated Nov 4, 2026, 9:01 PM
Why Is ADAMZ Up Today?
Adamas Trust's Series G preferred shares gained 1.36% following the release of parent company Adamas Pharmaceuticals' Q3 2026 earnings call transcript. The modest upward movement suggests investors are cautiously optimistic about the underlying company's financial performance and operational developments.
Bottom line: Today's 1.36% gain in ADAMZ reflects modest investor confidence following Adamas' Q3 earnings call, though the neutral sentiment of the headline suggests limited surprises or major catalysts. Investors should focus on the sustainability of the 7.000% dividend and the underlying pharmaceutical company's ability to maintain profitability amid competitive pressures—key drivers for preferred stock performance going forward.
ChartMill · Oct 21, 2026
Adamas Trust (NASDAQ:ADAMZ) Screens Strong on Accelerating Growth and Earnings Momentum
ADAMZ preferred clears Navellier’s growth screen, but weak balance sheet and dividend coverage warrant caution despite strong earnings and cash flow.
ChartMill · Sep 29, 2026
ADAMAS TRUST INC - ADAM 7 PERP (NASDAQ:ADAMZ): High Growth and Improving Fundamentals
ADAMAS TRUST (ADAMZ) clears all 8 Little Book growth rules with strong earnings and sales gains, but weak balance sheet scores raise risk.
Yahoo · Sep 22, 2026
Adamas Trust Inc's Dividend Analysis
This article first appeared on GuruFocus. Adamas Trust Inc (NASDAQ:ADAM) recently announced a total dividend of $0.30 per share, with the ex-dividend date set for Sept. 22, 2026. The distribution consists entirely of a $0.30 per share cash dividend, payable on Oct. 28, 2026.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
